Improving the T:N Ratio in Complex Patients

The TriNav Infusion System’s Pressure-Enabled Drug Delivery™ (PEDD™) approach improves the T:N (tumor to normal) ratio by precisely targeting the tumor while protecting against non-target embolization.^1,2,3

References

1. d’Abadie P, Walrand S, Goffette P, et al. Antireflux catheter improves tumor targeting in liver radioembolization with resin microspheres. Diagn Interv Radiol. 2021;27(6):768-773.

2. Titano JJ, Fischman AM, Cherian A, et al. End-hole versus microvalve infusion catheters in patients undergoing drug-eluting microspheres–TACE for solitary hepatocellular carcinoma tumors: a retrospective analysis. Cardiovasc Intervent Radiol. 2019;42(4):560-568.

3. Pasciak AS, McElmurray JH, Bourgeois AC, Heidel RE, Bradley YC. The impact of an antireflux catheter on target volume particulate distribution in liver-directed embolotherapy: a pilot study. J Vasc Interv Radiol. 2015;26(5):660-669.

Improving the T:N Ratio in Complex Patients

The TriNav Infusion System’s Pressure-Enabled Drug Delivery™ (PEDD™) approach improves the T:N (tumor to normal) ratio by precisely targeting the tumor while protecting against non-target embolization.1,2,3

References

The TriNav Infusion System’s Pressure-Enabled Drug Delivery™ (PEDD™) approach improves the T:N (tumor to normal) ratio by precisely targeting the tumor while protecting against non-target embolization.^1,2,3